We feature an interview of the selected supplier in our monthly customer newsletter, on our blog and social media. Below is this month's Spotlight on Cancer Genetics, Inc. (CGI, Nasdaq: CGIX) – a leader in enabling precision medicine for oncology from bench to bedside through the use of oncology biomarkers and molecular testing.
What is your company’s mission?
CGI’s mission is to empower personalized cancer treatment around the globe by developing and delivering products and services that drive the highest levels of patient value for optimal patient care management. CGI's innovative products and services are poised to transform cancer patient management, increase treatment efficacy, and reduce healthcare costs.
Describe your company’s most popular service offering.
Disease-specific, next-generation sequencing assays for heme and solid tumor indications.
Why should customers use your services?
Do you save time, money or provide access to innovation?
CGI’s research focuses on the development of state-of-the-art applications for the detection of genomic abnormalities in cancer and offers these applications to physicians and Biopharma clients for patient care and clinical trial programs.
CGI has a corporate culture that inspires innovation, respects knowledge and fosters leadership. CGI has a dedicated staff that takes pride in our specialized and streamlined laboratory services, superior turnaround time (TAT), enhanced reporting, EMR integration, and ongoing research and development for new innovative tests.